n-methylscopolamine has been researched along with rapacuronium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emala, CW; Jooste, EH; Sharma, A; Zhang, Y | 1 |
| Dolezal, V; El-Fakahany, EE; Jakubík, J; Randáková, A | 1 |
2 other study(ies) available for n-methylscopolamine and rapacuronium
| Article | Year |
|---|---|
Rapacuronium augments acetylcholine-induced bronchoconstriction via positive allosteric interactions at the M3 muscarinic receptor.
Topics: Acetylcholine; Animals; Bronchoconstriction; Drug Synergism; Guinea Pigs; In Vitro Techniques; Inositol Phosphates; Kinetics; Muscle Contraction; Muscle, Smooth; N-Methylscopolamine; Neuromuscular Nondepolarizing Agents; Parasympatholytics; Radioligand Assay; Receptor, Muscarinic M3; Stereoisomerism; Trachea; Vecuronium Bromide | 2005 |
Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptors.
Topics: Acetylcholine; Allosteric Regulation; Allosteric Site; Animals; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Female; Guanosine 5'-O-(3-Thiotriphosphate); Muscarinic Agonists; N-Methylscopolamine; Neuromuscular Nondepolarizing Agents; Radioligand Assay; Receptors, Muscarinic; Vecuronium Bromide | 2009 |